Enrolling by invitationPhase 1NCT03511846
Pain Biomarker Study
Studying Hemicrania continua
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The University of Texas Health Science Center, Houston
- Principal Investigator
- Mark Burish, MD PhD, M.DThe University of Texas Health Science Center, Houston
- Intervention
- Oral capsaicin(drug)
- Enrollment
- 371 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2028
Study locations (1)
- The University of Texas Health Science Center at Houston, Houston, Texas, United States
Collaborators
University of California, San Francisco
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03511846 on ClinicalTrials.gov